Claritev (CTEV) Financials

$29.53 +1.17 (+4.13%)

As of 03:55 PM Eastern

Annual Income Statements for Claritev

This table shows Claritev's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	12/31/2016	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	-45	-	-97	36	9.71	-521	102	-573	-92	-1,646	-284
Consolidated Net Income / (Loss)	-43	-	-97	36	9.71	-521	102	-573	-92	-1,646	-284
Net Income / (Loss) Continuing Operations	-22	-	-97	36	9.71	-521	102	-573	-92	-1,646	-287
Total Pre-Tax Income	-22	-	-97	44	11	-547	135	-561	-107	-1,771	-373
Total Revenue	0.00	-	0.00	658	625	-415	834	815	691	613	-400
Net Interest Income / (Expense)	-	-	-	-383	-376	-335	-267	-300	-325	-323	-390
Total Interest Income	-15	-	-	0.05	0.20	0.29	0.03	3.50	8.23	3.13	1.56
Investment Securities Interest Income	-	-	-	0.05	0.20	0.29	0.03	3.50	8.23	3.13	1.56
Total Interest Expense	-	-	0.00	383	376	336	267	303	333	326	392
Long-Term Debt Interest Expense	-	-	-	383	376	336	267	303	333	326	392
Total Non-Interest Income	-	-	-	1,041	1,001	-80	1,102	1,115	1,015	937	-10
Net Realized & Unrealized Capital Gains on Investments	-	-	-	0.00	18	-80	-16	35	54	5.91	-10
Total Non-Interest Expense	-	-	-	613	615	132	731	1,442	799	2,375	-30
Other Operating Expenses	-	-	0.00	227	225	356	326	371	379	390	228
Depreciation Expense	0.15	-	0.07	52	56	379	65	69	77	88	355
Amortization Expense	-	-	-	334	334	335	340	341	343	344	344
Impairment Charge	-	-	0.00	-	-	0.00	0.00	662	0.00	1,489	0.00
Restructuring Charge	-	-	-	-	-	-	-	-	0.00	64	8.05
Other Special Charges	0.32	-	-	-	-	-938	-	-	-	-	-965
Income Tax Expense	0.00	-	-0.17	8.11	0.80	-26	33	12	-15	-125	-89
Other Gains / (Losses), net	-	-	-	-	-	-	-	-	-	-	-2.67
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	-	-	-	-	-	-	-	-	0.00
Basic Earnings per Share	($7.83)	-	($1.01)	$0.09	$0.02	($1.11)	$0.16	($0.90)	($5.69)	($101.92)	($17.30)
Weighted Average Basic Shares Outstanding	5.71M	5.75M	95.80M	415.70M	415.70M	470.79M	651.01M	638.93M	16.13M	16.15M	16.43M
Diluted Earnings per Share	($7.83)	-	($1.01)	$0.09	$0.02	($1.11)	$0.16	($0.90)	($5.69)	($101.92)	($17.30)
Weighted Average Diluted Shares Outstanding	5.71M	5.75M	95.80M	415.70M	415.70M	470.79M	651.53M	638.93M	16.13M	16.15M	16.43M
Weighted Average Basic & Diluted Shares Outstanding	-	5.75M	95.80M	415.70M	415.70M	470.79M	638.60M	639.17M	644.37M	16.20M	16.55M

This table shows Claritev's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-24	-31	-540	-577	-391	-138	-71	-63	-70	-81	-74
Consolidated Net Income / (Loss)	-24	-31	-540	-577	-391	-138	-71	-63	-70	-81	-74
Net Income / (Loss) Continuing Operations	-24	-31	-540	-577	-391	-138	-71	-63	-70	-83	-74
Total Pre-Tax Income	-31	-32	-562	-604	-419	-186	-90	-83	-93	-107	-93
Total Revenue	170	87	159	153	150	151	-92	142	244	-926	145
Net Interest Income / (Expense)	-83	-164	-81	-81	-81	-81	-91	-99	0.47	-200	-99
Total Interest Income	1.51	1.12	0.93	0.55	1.25	0.41	0.49	0.32	0.47	0.28	0.18
Investment Securities Interest Income	1.51	1.12	0.93	0.55	1.25	0.41	0.49	0.32	0.47	0.28	0.18
Total Interest Expense	84	165	82	81	82	81	92	100	0.00	201	100
Long-Term Debt Interest Expense	84	-	82	81	82	81	92	100	-	-	100
Total Non-Interest Income	253	251	240	233	230	232	-1.02	242	243	-726	245
Net Realized & Unrealized Capital Gains on Investments	10	7.06	5.91	0.00	0.00	-	-1.02	0.00	-2.67	-6.69	0.00
Other Non-Interest Income	243	244	235	233	230	232	-	242	246	-	245
Total Non-Interest Expense	201	120	721	757	569	328	-2.30	225	337	-822	238
Other Operating Expenses	98	13	95	96	99	101	50	114	225	-222	127
Depreciation Expense	20	21	21	22	23	23	85	25	26	279	25
Amortization Expense	86	86	86	86	86	86	86	86	86	86	86
Restructuring Charge	-	-	0.00	0.00	0.00	64	7.79	0.09	0.00	0.17	0.00
Income Tax Expense	-6.88	-0.39	-22	-28	-27	-48	-19	-20	-24	-26	-19
Basic Earnings per Share	($1.49)	($1.95)	($33.40)	($35.78)	($24.25)	($8.54)	($4.38)	($3.81)	($4.23)	($4.90)	($4.41)
Weighted Average Basic Shares Outstanding	16.16M	16.13M	16.16M	16.12M	16.14M	16.15M	16.27M	16.45M	16.48M	16.43M	16.69M
Diluted Earnings per Share	($1.49)	($1.95)	($33.40)	($35.78)	($24.25)	($8.54)	($4.38)	($3.81)	($4.23)	($4.90)	($4.41)
Weighted Average Diluted Shares Outstanding	16.16M	16.13M	16.16M	16.12M	16.14M	16.15M	16.27M	16.45M	16.48M	16.43M	16.69M
Weighted Average Basic & Diluted Shares Outstanding	1.30B	644.37M	644.87M	645.72M	16.17M	16.20M	16.44M	16.47M	16.53M	16.55M	17.05M

This table details how cash moves in and out of Claritev's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	12/31/2016	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-15	0.91	21	-16	17	105	62	152	-259	-52	-1.33
Net Cash From Operating Activities	-6.59	-2.16	-50	292	284	377	405	372	172	108	117
Net Cash From Continuing Operating Activities	37	4.50	-50	292	284	377	405	372	172	108	117
Net Income / (Loss) Continuing Operations	0.00	0.00	-97	36	9.71	-521	102	-573	-92	-1,646	-284
Consolidated Net Income / (Loss)	-	-	-97	36	9.71	-521	102	-573	-92	-1,646	-284
Depreciation Expense	0.15	0.05	0.07	52	56	61	65	69	77	88	102
Amortization Expense	-	-	-	334	334	343	359	357	359	359	349
Non-Cash Adjustments to Reconcile Net Income	-6.50	-4.27	28	-93	-131	464	-78	464	-151	1,320	-20
Changes in Operating Assets and Liabilities, net	-0.24	2.06	18	-38	16	30	-44	55	-22	-14	-29
Net Cash From Investing Activities	0.02	5.11	-11	-64	-66	-211	-228	-104	-250	-118	-121
Net Cash From Continuing Investing Activities	0.02	5.11	-11	-64	-66	-211	-228	-104	-250	-118	-121
Purchase of Property, Leasehold Improvements and Equipment	-0.00	-	-	-64	-66	-71	-85	-90	-109	-118	-130
Purchase of Investment Securities	-	-	-	0.00	0.00	-140	-149	-15	-141	0.00	-4.75
Sale and/or Maturity of Investments	0.02	2.60	0.00	-	0.00	0.00	5.64	0.29	0.00	0.00	13
Net Cash From Financing Activities	3.20	0.39	82	-245	-201	-62	-115	-116	-181	-41	2.36
Net Cash From Continuing Financing Activities	3.20	0.39	82	-245	-201	-62	-115	-116	-181	-41	2.36
Issuance of Debt	5.50	0.63	-	5.00	-0.08	2,666	2,333	0.00	0.00	0.00	230
Issuance of Common Equity	0.26	0.00	59	-	-	-	0.00	0.00	0.51	1.10	1.74
Repayment of Debt	-0.15	-0.22	-	-250	-201	-3,308	-2,344	-113	-166	-29	-225
Repurchase of Common Equity	-1.55	-0.01	-1.68	0.00	0.00	-101	-100	0.00	-15	-10	0.00
Other Financing Activities, Net	-	-	0.00	0.00	0.00	682	-3.79	-2.46	-0.47	-3.36	-4.10
Cash Interest Paid	0.10	0.28	-	374	364	312	231	290	323	315	283
Cash Income Taxes Paid	0.00	0.00	-	117	115	3.92	132	124	100	80	44

This table details how cash moves in and out of Claritev's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	12	-26	-12	-10	38	-67	4.23	33	-17	-22	6.39
Net Cash From Operating Activities	72	28	50	18	73	-33	-30	61	20	66	-46
Net Cash From Continuing Operating Activities	72	28	50	18	73	-33	-30	61	20	66	-46
Net Income / (Loss) Continuing Operations	-24	-31	-540	-577	-391	-138	-71	-63	-70	-81	-74
Consolidated Net Income / (Loss)	-24	-31	-540	-577	-391	-138	-71	-63	-70	-81	-74
Depreciation Expense	20	21	21	22	23	23	25	25	26	26	25
Amortization Expense	90	90	86	88	96	89	88	87	91	85	87
Non-Cash Adjustments to Reconcile Net Income	-52	-26	466	522	317	15	-32	-21	40	-9.47	-4.90
Changes in Operating Assets and Liabilities, net	39	-26	16	-37	29	-23	-39	33	-67	46	-80
Net Cash From Investing Activities	-22	-31	-31	-25	-32	-30	-39	-25	-23	-35	-47
Net Cash From Continuing Investing Activities	-22	-31	-31	-25	-32	-30	-39	-25	-23	-35	-47
Purchase of Property, Leasehold Improvements and Equipment	-22	-31	-31	-25	-32	-30	-39	-25	-36	-30	-47
Net Cash From Financing Activities	-38	-22	-31	-3.04	-3.14	-3.65	73	-3.23	-14	-54	99
Net Cash From Continuing Financing Activities	-38	-22	-31	-3.04	-3.14	-3.65	73	-3.23	-14	-54	99
Issuance of Debt	-	-	0.00	-	-	-	130	-	95	5.00	145
Issuance of Common Equity	-	0.51	0.43	0.28	0.17	0.21	0.30	0.45	0.65	0.35	0.46
Repayment of Debt	-38	-21	-18	-3.31	-3.31	-3.86	-54	-3.67	-109	-59	-44
Other Financing Activities, Net	-0.00	-0.00	-3.35	-0.00	-	-0.00	-2.88	-	-0.61	-0.60	-2.86
Cash Interest Paid	62	100	61	98	60	97	82	36	130	36	129
Cash Income Taxes Paid	23	22	2.26	32	24	22	2.53	41	0.94	-0.42	1.64

This table presents Claritev's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	12/31/2016	12/31/2017	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	47	32	39	277	8,360	8,284	8,220	7,371	6,965	5,151	4,888
Cash and Due from Banks	0.77	1.68	21	128	22	127	185	334	72	17	17
Restricted Cash	-	-	-	-	-	-	3.05	6.51	9.95	13	12
Loans and Leases, Net of Allowance	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Premises and Equipment, Net	-	-	-	-	178	188	213	233	267	293	326
Goodwill	0.50	0.50	-	-	4,142	4,257	4,363	3,705	3,829	2,403	2,406
Intangible Assets	-	-	-	-	3,887	3,584	3,285	2,940	2,633	2,226	1,885
Other Assets	-	-	-	-	132	128	171	152	154	199	243
Total Liabilities & Shareholders' Equity	47	32	39	277	8,360	8,284	8,220	7,371	6,965	5,151	4,888
Total Liabilities	39	39	25	53	6,375	5,726	5,876	5,581	5,256	5,067	5,056
Short-Term Debt	0.00	0.78	-	-	19	22	33	33	38	104	80
Accrued Interest Payable	-	-	-	-	40	69	74	74	72	76	136
Other Short-Term Payables	-	-	-	-	26	22	35	68	57	34	45
Long-Term Debt	-	-	-	0.00	5,397	4,578	4,879	4,742	4,533	4,510	4,580
Other Long-Term Liabilities	-	-	-	-	892	1,035	855	663	556	343	214
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	7.95	-6.99	5.60	224	1,985	2,558	2,345	1,791	1,709	84	-167
Total Preferred & Common Equity	7.95	-6.99	5.60	224	1,985	2,558	2,345	1,791	1,709	84	-174
Preferred Stock	-	-	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	7.95	-6.99	5.59	224	1,985	2,558	2,345	1,791	1,709	84	-174
Common Stock	93	94	102	552	1,348	2,530	2,312	2,331	2,349	2,373	2,398
Retained Earnings	-81	-96	-97	-328	638	117	225	-348	-499	-2,145	-2,429
Treasury Stock	-9.81	-9.81	-	-	0.00	-90	-192	-192	-128	-139	-139
Accumulated Other Comprehensive Income / (Loss)	5.30	4.91	-	-	-	-	-	0.00	-12	-5.06	-4.17
Noncontrolling Interest	-	-	-	-	-	-	-	-	-	0.00	6.73

This table presents Claritev's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	1,430	1,267	1,260	7,058	6,367	5,742	5,319	5,085	5,072	4,990	4,839
Cash and Due from Banks	607	150	107	101	59	49	87	23	56	39	21
Restricted Cash	-	-	-	6.29	10	10	11	11	11	11	13
Loans and Leases, Net of Allowance	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Premises and Equipment, Net	-	-	-	256	278	287	293	304	308	317	344
Goodwill	-	-	-	3,829	3,313	2,759	2,403	2,403	2,403	2,403	2,406
Intangible Assets	-	-	-	2,719	2,545	2,459	2,367	2,140	2,054	1,968	1,799
Other Assets	-	-	-	146	162	179	145	203	239	251	256
Total Liabilities & Shareholders' Equity	1,430	1,267	1,260	7,058	6,367	5,742	5,319	5,085	5,072	4,990	4,839
Total Liabilities	790	622	661	5,308	5,196	5,139	5,112	5,070	5,112	5,092	5,074
Short-Term Debt	163	0.00	0.00	33	36	40	40	54	63	58	79
Accrued Interest Payable	-	-	-	106	135	108	104	105	153	102	91
Other Short-Term Payables	-	-	-	33	23	32	57	22	38	53	20
Long-Term Debt	382	383	384	4,558	4,511	4,511	4,510	4,600	4,613	4,617	4,699
Other Long-Term Liabilities	-	-	-	579	491	447	400	290	246	262	185
Commitments & Contingencies	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	641	646	599	1,750	1,170	603	208	15	-40	-102	-234
Total Preferred & Common Equity	641	646	599	1,750	1,170	603	208	15	-40	-102	-241
Preferred Stock	0.06	0.06	0.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	641	645	599	1,750	1,170	603	208	15	-40	-102	-241
Common Stock	1,652	1,654	1,667	2,343	2,351	2,359	2,366	2,377	2,384	2,391	2,403
Retained Earnings	-1,012	-1,008	-1,068	-468	-1,039	-1,616	-2,007	-2,216	-2,279	-2,349	-2,503
Treasury Stock	-	-	-	-126	-139	-139	-139	-139	-139	-139	-139
Accumulated Other Comprehensive Income / (Loss)	-	-	-	0.38	-3.24	-1.12	-12	-6.69	-5.93	-5.14	-2.35
Noncontrolling Interest	-	-	-	-	-	-	-	-	-	-	6.73

This table displays calculated financial ratios and metrics derived from Claritev's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2016	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	-	-	-	0.00	0.00	667,461,272.00	638,276,295.00	639,123,203.00	649,486,255.00	16,171,197.00	16,525,644.00
DEI Adjusted Shares Outstanding	-	-	-	0.00	0.00	16,686,532.00	15,956,907.00	15,978,080.00	16,237,156.00	16,171,197.00	16,525,644.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	0.00	0.00	-31.20	6.40	-35.86	-5.65	-101.78	-17.20
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	0.00%	0.00%	0.00%	-4.94%	-166.39%	301.00%	-2.36%	-15.24%	-11.18%	-165.30%
EBITDA Growth	100.85%	-179,270.37%	100.00%	0.00%	-7.03%	-135.77%	468.07%	-138.24%	262.85%	-500.38%	106.12%
EBIT Growth	100.00%	0.00%	100.00%	0.00%	-76.29%	-5,304.18%	118.81%	-710.36%	82.77%	-1,529.09%	78.98%
NOPAT Growth	100.00%	0.00%	0.00%	0.00%	-73.19%	-4,042.69%	120.25%	-666.93%	82.63%	-1,524.57%	78.94%
Net Income Growth	0.00%	0.00%	0.00%	0.00%	-73.19%	-5,461.11%	119.61%	-661.24%	83.99%	-1,694.86%	82.73%
EPS Growth	0.00%	0.00%	0.00%	0.00%	-77.78%	-5,650.00%	114.41%	-662.50%	83.99%	-1,691.21%	83.03%
Operating Cash Flow Growth	67.30%	-2,239.05%	0.00%	0.00%	-2.73%	32.73%	7.24%	-7.99%	-53.88%	-37.33%	9.02%
Free Cash Flow Firm Growth	5,662.63%	-306.77%	0.00%	0.00%	0.00%	98.11%	84.67%	1,279.35%	-16.93%	63.22%	-116.54%
Invested Capital Growth	-305.67%	34.25%	705.19%	0.00%	0.00%	-3.29%	1.38%	-9.53%	-4.35%	-25.19%	-4.36%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	475.28%	-3.55%	-13.65%	11.75%	-58.03%
EBITDA Q/Q Growth	100.49%	0.00%	0.00%	0.00%	0.00%	0.00%	82.23%	-135.71%	191.69%	-11.55%	2,069.97%
EBIT Q/Q Growth	100.00%	0.00%	0.00%	0.00%	0.00%	0.00%	183.67%	-583.85%	86.40%	-8.84%	18.02%
NOPAT Q/Q Growth	100.00%	0.00%	0.00%	0.00%	0.00%	0.00%	226.57%	-530.15%	84.93%	-9.58%	17.51%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	206.13%	-660.78%	87.09%	-6.92%	16.80%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	206.67%	-662.50%	87.09%	-6.89%	16.55%
Operating Cash Flow Q/Q Growth	38.96%	-73.53%	0.00%	0.00%	0.00%	0.00%	-2.84%	-1.47%	0.01%	-36.22%	565.67%
Free Cash Flow Firm Q/Q Growth	-12.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	103.48%	-58.20%	-24.10%	57.05%
Invested Capital Q/Q Growth	-3.30%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-10.65%	-0.96%	-1.27%	-1.75%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
EBITDA Margin	0.00%	0.00%	0.00%	65.48%	64.04%	0.00%	63.18%	-24.75%	47.54%	-214.33%	0.00%
EBIT Margin	0.00%	0.00%	0.00%	6.74%	1.68%	0.00%	12.33%	-77.06%	-15.66%	-287.28%	0.00%
Profit (Net Income) Margin	0.00%	0.00%	0.00%	5.51%	1.55%	0.00%	12.23%	-70.33%	-13.28%	-268.36%	0.00%
Tax Burden Percent	0.00%	99.83%	0.00%	81.71%	92.40%	95.18%	75.36%	102.17%	85.65%	92.95%	76.20%
Interest Burden Percent	0.00%	100.00%	0.00%	100.00%	100.00%	100.00%	131.69%	89.32%	98.99%	100.50%	100.72%
Effective Tax Rate	0.00%	0.00%	0.00%	18.29%	7.60%	0.00%	24.64%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.26%	0.00%	1.08%	-6.36%	-1.19%	-22.59%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.26%	0.00%	1.59%	-9.11%	-1.52%	-31.43%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.72%	0.00%	3.09%	-21.35%	-4.05%	-160.98%	0.00%
Return on Equity (ROE)	0.00%	13,907.19%	0.00%	0.00%	0.98%	-22.92%	4.16%	-27.71%	-5.24%	-183.57%	683.76%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	-199.74%	-1.92%	-0.30%	3.65%	3.26%	6.23%	-1.23%
Operating Return on Assets (OROA)	0.00%	0.00%	0.00%	0.00%	0.13%	0.00%	1.25%	-8.05%	-1.51%	-29.08%	0.00%
Return on Assets (ROA)	0.00%	0.00%	0.00%	0.00%	0.12%	0.00%	1.24%	-7.35%	-1.28%	-27.17%	0.00%
Return on Common Equity (ROCE)	0.00%	13,957.22%	0.00%	0.00%	0.98%	-22.92%	4.16%	-27.71%	-5.24%	-183.57%	739.06%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-1,726.29%	-103.38%	0.00%	0.49%	-20.35%	4.35%	-32.00%	-5.37%	-1,958.81%	163.47%
Net Operating Profit after Tax (NOPAT)	0.00	-66	0.00	36	9.71	-383	78	-439	-76	-1,240	-261
NOPAT Margin	0.00%	0.00%	0.00%	5.51%	1.55%	0.00%	9.29%	-53.94%	-11.05%	-202.16%	0.00%
Net Nonoperating Expense Percent (NNEP)	0.00%	-161.53%	0.00%	0.00%	0.00%	2.75%	-0.52%	2.76%	0.33%	8.84%	0.50%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	0.00%	0.00%	0.00%	93.26%	98.32%	0.00%	87.67%	177.06%	115.66%	387.28%	0.00%
Earnings before Interest and Taxes (EBIT)	0.00	-97	0.00	44	11	-547	103	-628	-108	-1,762	-370
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	0.05	-97	0.00	431	400	-143	527	-202	328	-1,314	80
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	11.82	0.00	0.00	0.50	2.08	1.21	0.41	0.55	2.84	0.00
Price to Tangible Book Value (P/TBV)	0.00	11.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	0.00	1.52	1.60	0.00	3.39	0.90	1.35	0.39	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	27.61	102.99	0.00	27.70	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	3.62%	0.97%	0.00%	3.61%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.86	1.37	1.04	0.79	0.86	1.03	1.19
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.00	0.00	10.23	0.00	9.05	6.35	7.86	7.86	0.00
Enterprise Value to EBITDA (EV/EBITDA)	98.18	0.00	0.00	0.00	15.97	0.00	14.32	0.00	16.52	0.00	66.41
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	608.47	0.00	73.42	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	658.54	0.00	97.42	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	22.49	25.99	18.66	13.88	31.59	44.82	45.56
Enterprise Value to Free Cash Flow (EV/FCFF)	0.15	0.00	0.00	0.00	0.00	0.00	0.00	20.50	25.89	14.10	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	-0.11	0.00	0.00	0.00	2.73	1.80	2.10	2.67	2.67	54.91	-27.88
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	2.72	1.79	2.08	2.65	2.65	53.67	-27.40
Financial Leverage	-13.91	27.65	-0.65	0.00	2.73	2.20	1.94	2.34	2.67	5.12	-111.53
Leverage Ratio	81.85	-50.81	1.38	0.00	4.21	3.66	3.37	3.77	4.10	6.76	-120.73
Compound Leverage Factor	0.00	-50.81	0.00	0.00	4.21	3.66	4.43	3.37	4.06	6.79	-121.60
Debt to Total Capital	-12.62%	0.00%	0.00%	0.00%	73.18%	64.27%	67.69%	72.73%	72.78%	98.21%	103.72%
Short-Term Debt to Total Capital	-12.62%	0.00%	0.00%	0.00%	0.26%	0.30%	0.46%	0.50%	0.60%	2.21%	1.78%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	72.92%	63.96%	67.23%	72.23%	72.18%	96.00%	101.94%
Preferred Equity to Total Capital	0.00%	0.09%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.15%
Common Equity to Total Capital	112.62%	99.91%	100.00%	0.00%	26.82%	35.73%	32.31%	27.27%	27.22%	1.79%	-3.87%
Debt to EBITDA	14.50	0.00	0.00	0.00	13.53	-32.12	9.32	-23.68	13.92	-3.51	57.90
Net Debt to EBITDA	-27.74	0.00	0.00	0.00	13.47	-31.23	8.96	-22.00	13.67	-3.49	57.54
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	13.48	-31.97	9.26	-23.52	13.81	-3.43	56.90
Debt to NOPAT	0.00	0.00	0.00	0.00	557.80	-12.02	63.37	-10.87	-59.89	-3.72	-17.85
Net Debt to NOPAT	0.00	0.00	0.00	0.00	555.55	-11.69	60.94	-10.09	-58.82	-3.70	-17.74
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	555.83	-11.96	62.94	-10.79	-59.39	-3.64	-17.54
Noncontrolling Interest Sharing Ratio	0.00%	-0.36%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-8.09%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	36	-74	0.00	0.00	-7,392	-139	-21	252	209	342	-57
Operating Cash Flow to CapEx	0.00%	0.00%	0.00%	459.91%	428.09%	532.92%	478.41%	414.96%	157.76%	91.11%	90.53%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	-19.64	-0.42	-0.08	0.83	0.63	1.05	-0.14
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.76	0.76	1.12	1.51	1.23	0.52	0.33	0.30
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.60	0.58	0.91	1.20	0.93	0.19	-0.03	-0.03
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	0.00	0.00	0.00	0.07	0.00	0.10	0.10	0.10	0.10	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	3.51	0.00	4.16	3.65	2.76	2.19	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	-24	-16	96	0.00	7,401	7,158	7,257	6,565	6,279	4,698	4,493
Invested Capital Turnover	0.00	0.00	0.00	0.00	0.17	0.00	0.12	0.12	0.11	0.11	0.00
Increase / (Decrease) in Invested Capital	-36	8.23	111	0.00	7,401	-243	99	-692	-286	-1,582	-205
Enterprise Value (EV)	5.30	45	-128	0.00	6,394	9,806	7,551	5,169	5,424	4,823	5,345
Market Capitalization	6.80	66	0.00	1,000	1,000	5,333	2,828	735	935	239	706
Book Value per Share	($1.21)	$0.95	$0.00	$0.00	$4.78	$3.83	$3.67	$2.80	$2.63	$5.20	($10.52)
Tangible Book Value per Share	($1.30)	$0.95	$0.00	$0.00	($14.54)	($7.92)	($8.31)	($7.60)	($7.32)	($281.08)	($270.15)
Total Capital	-6.21	5.60	224	0.00	7,401	7,158	7,257	6,565	6,279	4,698	4,493
Total Debt	0.78	0.00	0.00	0.00	5,416	4,600	4,912	4,775	4,570	4,614	4,660
Total Long-Term Debt	0.00	0.00	0.00	0.00	5,397	4,578	4,879	4,742	4,533	4,510	4,580
Net Debt	-1.50	-21	-128	0.00	5,394	4,473	4,724	4,434	4,489	4,584	4,632
Capital Expenditures (CapEx)	-2.52	0.00	0.00	64	66	71	85	90	109	118	130
Net Nonoperating Expense (NNE)	0.00	31	0.00	0.00	0.00	138	-25	133	15	406	23
Net Nonoperating Obligations (NNO)	-17	-21	-128	0.00	5,416	4,600	4,912	4,775	4,570	4,614	4,660
Total Depreciation and Amortization (D&A)	0.05	0.07	0.00	386	390	404	424	426	436	447	451
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($1.01)	$0.00	$0.00	$0.00	($1.11)	$0.16	($0.90)	($5.60)	($101.92)	($17.30)
Adjusted Weighted Average Basic Shares Outstanding	5.75M	95.80M	0.00	0.00	0.00	668.92M	651.01M	638.93M	16.13M	16.15M	16.43M
Adjusted Diluted Earnings per Share	$0.00	($1.01)	$0.00	$0.00	$0.00	($1.11)	$0.16	($0.90)	($5.60)	($101.92)	($17.30)
Adjusted Weighted Average Diluted Shares Outstanding	5.75M	95.80M	0.00	0.00	0.00	668.92M	651.53M	638.93M	16.13M	16.15M	16.43M
Adjusted Basic & Diluted Earnings per Share	$0.00	($1.01)	$0.00	$0.00	$0.00	($1.11)	$0.16	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	5.75M	95.80M	0.00	0.00	0.00	470.79M	638.60M	639.17M	16.11M	16.20M	16.55M
Normalized Net Operating Profit after Tax (NOPAT)	0.00	-66	0.00	36	9.71	-1,039	78	24	-76	-153	-931
Normalized NOPAT Margin	0.00%	0.00%	0.00%	5.51%	1.55%	0.00%	9.29%	2.96%	-11.05%	-24.93%	0.00%
Pre Tax Income Margin	0.00%	0.00%	0.00%	6.74%	1.68%	0.00%	16.23%	-68.83%	-15.50%	-288.72%	0.00%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.12	0.03	-1.63	0.38	-2.07	-0.32	-5.40	-0.94
NOPAT to Interest Expense	0.00	0.00	0.00	0.09	0.03	-1.14	0.29	-1.45	-0.23	-3.80	-0.67
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	-0.05	-0.15	-1.84	0.07	-2.36	-0.65	-5.76	-1.28
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	-0.07	-0.15	-1.35	-0.03	-1.74	-0.56	-4.16	-1.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-1.74%	0.00%	0.00%	0.00%	-19.43%	97.96%	0.00%	-16.60%	-0.63%	0.00%

This table displays calculated financial ratios and metrics derived from Claritev's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	649,480,795.00	649,486,255.00	644,372,197.00	644,868,398.00	645,723,791.00	16,171,197.00	16,198,024.00	16,436,369.00	16,474,835.00	16,525,644.00	16,552,723.00
DEI Adjusted Shares Outstanding	16,237,020.00	16,237,156.00	16,109,305.00	16,121,710.00	16,143,095.00	16,171,197.00	16,198,024.00	16,436,369.00	16,474,835.00	16,525,644.00	16,552,723.00
DEI Earnings Per Adjusted Shares Outstanding	-1.49	-1.93	-33.50	-35.77	-24.25	-8.53	-4.40	-3.81	-4.23	-4.88	-4.44
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-2.36%	-55.70%	-17.62%	-36.39%	-11.87%	74.23%	-157.91%	-7.03%	62.57%	-711.97%	257.67%
EBITDA Growth	-34.01%	112.80%	-516.36%	-893.22%	-480.89%	-183.28%	104.92%	105.88%	107.73%	110.06%	-10.82%
EBIT Growth	-442.80%	95.44%	-29,637.07%	-1,209.44%	-1,249.96%	-437.95%	84.00%	86.28%	77.71%	41.04%	-3.13%
NOPAT Growth	-210.02%	95.10%	-188,261.00%	-1,209.44%	-1,249.96%	-485.74%	84.00%	86.28%	77.71%	42.56%	-3.17%
Net Income Growth	-222.34%	95.17%	-258,324.40%	-1,485.72%	-1,521.25%	-339.51%	86.79%	89.14%	82.18%	41.60%	-3.14%
EPS Growth	-222.34%	95.17%	-258,324.40%	-1,485.72%	-1,527.52%	-337.95%	86.89%	89.35%	82.56%	42.62%	-0.68%
Operating Cash Flow Growth	-33.86%	0.05%	-22.58%	140.35%	1.00%	-220.62%	-160.46%	231.53%	-72.74%	298.38%	-52.31%
Free Cash Flow Firm Growth	113.45%	10.72%	-64.03%	-5.90%	30.75%	450.70%	213.19%	-44.40%	-90.72%	-91.06%	-93.94%
Invested Capital Growth	-13.71%	-4.35%	-11.02%	-19.54%	-24.95%	-25.19%	-18.35%	-10.06%	-3.89%	-4.36%	-2.67%
Revenue Q/Q Growth	-29.21%	-48.96%	83.27%	-3.93%	-1.93%	0.90%	-160.92%	1.89%	71.49%	-479.84%	115.69%
EBITDA Q/Q Growth	26.53%	-1.26%	-738.59%	-8.70%	39.24%	78.41%	134.52%	34.22%	-20.19%	-71.91%	206.12%
EBIT Q/Q Growth	32.81%	-5.95%	-1,564.97%	-7.60%	30.73%	57.78%	49.17%	7.72%	-12.58%	-11.66%	11.10%
NOPAT Q/Q Growth	32.81%	-2.44%	-1,667.93%	-7.60%	30.73%	55.55%	51.72%	7.72%	-12.58%	-14.52%	13.28%
Net Income Q/Q Growth	33.61%	-30.01%	-1,619.25%	-6.86%	32.13%	64.76%	48.31%	12.17%	-11.36%	-15.51%	8.70%
EPS Q/Q Growth	33.61%	-30.01%	-1,619.25%	-6.86%	32.22%	64.78%	48.71%	13.01%	-11.02%	-15.84%	10.00%
Operating Cash Flow Q/Q Growth	838.43%	-61.59%	79.47%	-62.85%	294.36%	-145.87%	10.05%	303.74%	-67.57%	233.82%	-169.06%
Free Cash Flow Firm Q/Q Growth	11.95%	-73.26%	19.50%	163.05%	55.56%	12.62%	-32.04%	-53.30%	-74.05%	8.52%	-53.92%
Invested Capital Q/Q Growth	-1.03%	-0.96%	-8.95%	-9.85%	-7.69%	-1.27%	-0.63%	-0.70%	-1.35%	-1.75%	1.12%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
EBITDA Margin	46.35%	89.67%	-285.79%	-323.35%	-200.32%	-42.86%	0.00%	20.46%	9.52%	0.00%	13.74%
EBIT Margin	-18.23%	-37.85%	-353.00%	-395.36%	-279.27%	-116.86%	0.00%	-58.34%	-38.30%	0.00%	-63.78%
Profit (Net Income) Margin	-14.19%	-36.15%	-339.11%	-377.20%	-261.06%	-91.19%	0.00%	-44.07%	-28.62%	0.00%	-50.62%
Tax Burden Percent	77.84%	98.79%	96.09%	95.45%	93.50%	74.12%	79.36%	75.53%	74.71%	75.36%	79.33%
Interest Burden Percent	100.00%	96.68%	99.98%	99.96%	99.98%	105.27%	100.00%	100.00%	100.00%	102.56%	100.04%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-1.49%	-2.75%	-26.72%	-27.24%	-19.33%	-9.62%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-1.54%	-2.95%	-29.90%	-30.59%	-21.49%	-9.79%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	-3.50%	-7.88%	-92.84%	-118.49%	-100.35%	-50.14%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-4.99%	-10.63%	-119.55%	-145.74%	-119.69%	-59.76%	0.00%	-235.47%	-646.34%	683.76%	260.96%
Cash Return on Invested Capital (CROIC)	7.32%	3.26%	3.93%	6.77%	8.12%	6.23%	2.70%	-0.52%	-2.82%	-1.23%	-3.01%
Operating Return on Assets (OROA)	-1.91%	-3.65%	-34.12%	-34.94%	-24.77%	-11.83%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (ROA)	-1.49%	-3.48%	-32.78%	-33.33%	-23.15%	-9.23%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Common Equity (ROCE)	-4.99%	-10.63%	-119.55%	-145.74%	-119.69%	-59.76%	0.00%	-235.47%	-646.34%	739.06%	268.96%
Return on Equity Simple (ROE_SIMPLE)	-40.61%	0.00%	-53.96%	-194.24%	-741.59%	0.00%	0.00%	1,662.26%	335.52%	0.00%	118.82%
Net Operating Profit after Tax (NOPAT)	-22	-22	-393	-423	-293	-130	-63	-58	-65	-75	-65
NOPAT Margin	-12.76%	-25.62%	-247.10%	-276.76%	-195.49%	-86.11%	0.00%	-40.84%	-26.81%	0.00%	-44.66%
Net Nonoperating Expense Percent (NNEP)	0.05%	0.20%	3.19%	3.34%	2.15%	0.17%	0.18%	0.10%	0.10%	0.12%	0.18%
SG&A Expenses to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	118.23%	137.85%	453.00%	495.36%	379.27%	216.86%	0.00%	158.34%	138.30%	0.00%	163.78%
Earnings before Interest and Taxes (EBIT)	-31	-33	-562	-605	-419	-177	-90	-83	-93	-104	-93
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	79	78	-455	-494	-300	-65	22	29	23	6.52	20
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.62	0.55	0.45	0.42	0.59	2.84	22.54	0.00	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.36	1.35	0.80	0.44	0.22	0.39	0.92	0.00	0.00	0.00	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.88	0.86	0.87	0.92	0.96	1.03	1.06	1.15	1.20	1.19	1.11
Enterprise Value to Revenue (EV/Rev)	6.97	7.86	7.62	8.33	8.34	7.86	13.69	0.00	0.00	0.00	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	16.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	66.41	64.31
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	32.46	31.59	31.81	28.23	27.12	44.82	177.91	75.77	312.00	45.56	49.41
Enterprise Value to Free Cash Flow (EV/FCFF)	11.12	25.89	20.94	12.11	10.16	14.10	35.35	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.62	2.67	3.89	7.54	21.92	54.91	313.89	-117.16	-45.91	-27.88	-20.38
Long-Term Debt to Equity	2.61	2.65	3.85	7.48	21.73	53.67	310.26	-115.59	-45.33	-27.40	-20.05
Financial Leverage	2.27	2.67	3.10	3.87	4.67	5.12	7.76	16.38	87.26	-111.53	-42.95
Leverage Ratio	3.64	4.10	4.59	5.43	6.32	6.76	9.66	19.19	97.51	-120.73	-45.19
Compound Leverage Factor	3.64	3.96	4.59	5.43	6.32	7.11	9.66	19.19	97.51	-123.82	-45.21
Debt to Total Capital	72.40%	72.78%	79.53%	88.29%	95.64%	98.21%	99.68%	100.86%	102.23%	103.72%	105.16%
Short-Term Debt to Total Capital	0.51%	0.60%	0.63%	0.78%	0.85%	2.21%	1.15%	1.35%	1.28%	1.78%	1.73%
Long-Term Debt to Total Capital	71.89%	72.18%	78.90%	87.51%	94.79%	96.00%	98.53%	99.51%	100.95%	101.94%	103.43%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.15%	0.15%
Common Equity to Total Capital	27.60%	27.22%	20.47%	11.71%	4.36%	1.79%	0.32%	-0.86%	-2.23%	-3.87%	-5.31%
Debt to EBITDA	-12.82	13.92	-18.76	-5.70	-3.86	-3.51	-5.56	-14.27	-1,144.18	57.90	61.20
Net Debt to EBITDA	-12.52	13.67	-18.47	-5.62	-3.78	-3.49	-5.52	-14.06	-1,131.78	57.54	60.76
Long-Term Debt to EBITDA	-12.73	13.81	-18.61	-5.64	-3.83	-3.43	-5.49	-14.08	-1,129.88	56.90	60.19
Debt to NOPAT	-9.07	-59.89	-9.69	-5.29	-4.02	-3.72	-5.12	-8.59	-14.77	-17.85	-18.16
Net Debt to NOPAT	-8.85	-58.82	-9.54	-5.22	-3.94	-3.70	-5.08	-8.47	-14.61	-17.74	-18.03
Long-Term Debt to NOPAT	-9.00	-59.39	-9.61	-5.24	-3.99	-3.64	-5.06	-8.47	-14.58	-17.54	-17.86
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-8.09%	-3.06%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	986	264	315	829	1,289	1,451	986	461	120	130	60
Operating Cash Flow to CapEx	321.75%	88.38%	162.77%	72.59%	229.79%	-109.79%	-77.33%	248.70%	54.85%	221.63%	-97.89%
Free Cash Flow to Firm to Interest Expense	11.69	1.59	3.83	10.21	15.76	17.86	10.77	4.62	0.00	0.65	0.60
Operating Cash Flow to Interest Expense	0.86	0.17	0.60	0.23	0.89	-0.41	-0.33	0.61	0.00	0.33	-0.46
Operating Cash Flow Less CapEx to Interest Expense	0.59	-0.02	0.23	-0.09	0.50	-0.79	-0.75	0.37	0.00	0.18	-0.93
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.10	0.10	0.10	0.09	0.09	0.10	0.06	0.00	0.00	0.00	0.00
Fixed Asset Turnover	3.33	2.76	2.54	2.13	2.00	2.19	1.24	0.00	0.00	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	6,340	6,279	5,718	5,154	4,758	4,698	4,668	4,636	4,573	4,493	4,544
Invested Capital Turnover	0.12	0.11	0.11	0.10	0.10	0.11	0.07	0.00	0.00	0.00	0.00
Increase / (Decrease) in Invested Capital	-1,007	-286	-708	-1,252	-1,582	-1,582	-1,049	-519	-185	-205	-125
Enterprise Value (EV)	5,574	5,424	5,001	4,742	4,577	4,823	4,954	5,350	5,499	5,345	5,020
Market Capitalization	1,091	935	523	250	123	239	334	742	874	706	270
Book Value per Share	$2.69	$2.63	$1.82	$0.94	$0.32	$5.20	$0.92	($2.43)	($6.18)	($10.52)	($14.57)
Tangible Book Value per Share	($7.39)	($7.32)	($7.27)	($7.16)	($7.07)	($281.08)	($279.58)	($273.63)	($271.53)	($270.15)	($268.58)
Total Capital	6,340	6,279	5,718	5,154	4,758	4,698	4,668	4,636	4,573	4,493	4,544
Total Debt	4,591	4,570	4,547	4,551	4,551	4,614	4,653	4,676	4,675	4,660	4,778
Total Long-Term Debt	4,558	4,533	4,511	4,511	4,510	4,510	4,600	4,613	4,617	4,580	4,699
Net Debt	4,483	4,489	4,478	4,492	4,453	4,584	4,620	4,608	4,624	4,632	4,743
Capital Expenditures (CapEx)	22	31	31	25	32	30	39	25	36	30	47
Net Nonoperating Expense (NNE)	2.43	9.15	146	154	98	7.67	8.41	4.59	4.40	5.73	8.66
Net Nonoperating Obligations (NNO)	4,591	4,570	4,547	4,551	4,551	4,614	4,653	4,676	4,675	4,660	4,778
Total Depreciation and Amortization (D&A)	110	111	107	110	118	112	112	112	117	111	113
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.60)	($78.00)	($33.20)	($35.60)	($24.25)	($8.54)	($4.38)	($3.81)	($4.23)	($4.90)	($4.41)
Adjusted Weighted Average Basic Shares Outstanding	16.16M	403.21K	16.16M	16.12M	16.14M	16.15M	16.27M	16.45M	16.48M	16.43M	16.69M
Adjusted Diluted Earnings per Share	($1.60)	($78.00)	($33.20)	($35.60)	($24.25)	($8.54)	($4.38)	($3.81)	($4.23)	($4.90)	($4.41)
Adjusted Weighted Average Diluted Shares Outstanding	16.16M	403.21K	16.16M	16.12M	16.14M	16.15M	16.27M	16.45M	16.48M	16.43M	16.69M
Adjusted Basic & Diluted Earnings per Share	$0.00	($78.00)	$0.00	$0.00	$0.00	($8.54)	$0.00	$0.00	$0.00	($4.90)	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	32.47M	16.11M	16.12M	16.14M	16.17M	16.20M	16.44M	16.47M	16.53M	16.55M	17.05M
Normalized Net Operating Profit after Tax (NOPAT)	-23	-22	-30	-36	-40	-47	-219	-58	-65	-75	-65
Normalized NOPAT Margin	-13.64%	-25.62%	-18.80%	-23.26%	-26.68%	-31.32%	0.00%	-40.80%	-26.81%	0.00%	-44.66%
Pre Tax Income Margin	-18.23%	-36.59%	-352.92%	-395.20%	-279.21%	-123.02%	0.00%	-58.34%	-38.30%	0.00%	-63.81%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-0.37	-0.20	-6.83	-7.45	-5.12	-2.18	-0.98	-0.83	0.00	-0.52	-0.93
NOPAT to Interest Expense	-0.26	-0.13	-4.78	-5.22	-3.58	-1.60	-0.69	-0.58	0.00	-0.37	-0.65
EBIT Less CapEx to Interest Expense	-0.63	-0.39	-7.21	-7.76	-5.51	-2.55	-1.40	-1.08	0.00	-0.67	-1.40
NOPAT Less CapEx to Interest Expense	-0.52	-0.32	-5.16	-5.53	-3.97	-1.98	-1.11	-0.83	0.00	-0.52	-1.12
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-1.85%	-16.60%	-3.15%	-1.06%	-0.81%	-0.63%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Claritev (NYSE: CTEV) shows a business that is still generating substantial revenue, but profitability, leverage, and cash flow remain under pressure. Over the last several quarters, the company has stayed in the red, and its balance sheet is carrying a very large debt load relative to equity.

Non-interest revenue has remained meaningful, with Q1 2026 total revenue of $145.3 million, supported by $244.7 million of other non-interest income offset by heavy interest expense.
Operating cash flow turned negative again in Q1 2026 at $(45.8) million, but the company still generated positive operating cash flow in some prior quarters, including $66.3 million in Q4 2025 and $61.2 million in Q2 2025.
Capital spending appears modest relative to the size of the business, with Q1 2026 purchases of property and equipment at $(46.8) million.
Interest expense has come down somewhat from prior periods, with total interest expense of $99.5 million in Q1 2026 versus $200.6 million in Q4 2025.
The company’s share count has been relatively stable in recent quarters, with weighted average basic shares around 16.7 million in Q1 2026.
The balance sheet still carries substantial intangible and goodwill assets, which together totaled more than $4.2 billion in Q1 2026.
MultiPlan remains unprofitable, posting a Q1 2026 net loss of $(73.6) million, or $(4.41) per share.
Losses have persisted for several quarters, including $(80.6) million in Q4 2025 and $(69.8) million in Q3 2025.
Debt is the biggest concern. As of Q1 2026, the company had about $4.77 billion in total debt, including $4.70 billion in long-term debt.
Equity is deeply negative at $(234.4) million, indicating liabilities exceed shareholders’ equity on the balance sheet.

Looking at the broader trend, Claritev’s revenue mix has been relatively steady, but it has not been enough to offset large operating expenses, amortization, and especially interest costs. The company’s quarterly losses have generally stayed large, and cash from operations has been volatile rather than consistently positive.

The balance sheet also shows limited financial flexibility. Cash and restricted cash totaled only about $34.7 million in Q1 2026, which is small compared with the debt burden. Even though the company accessed additional debt financing in Q1 2026, that helped liquidity only in the short term and added to leverage.

Bottom line: Claritev has revenue scale, but the combination of persistent net losses, heavy debt, and negative equity makes the stock look financially risky. Investors will likely want to see a sustained improvement in operating profitability and cash generation before the outlook improves meaningfully.

07/15/26 04:58 PM ETAI Generated. May Contain Errors.

Claritev Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Claritev's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Claritev's net income appears to be on an upward trend, with a most recent value of -$284.28 million in 2025, rising from -$43 million in 2014. The previous period was -$1.65 billion in 2024. See Claritev's forecast for analyst expectations on what's next for the company.

Over the last 10 years, Claritev's total revenue changed from $0.00 in 2014 to -$400.49 million in 2025, a change of -40,048,800,000.0%.

Claritev's total liabilities were at $5.06 billion at the end of 2025, a 0.2% decrease from 2024, and a 12,945.1% increase since 2014.

In the past 10 years, Claritev's cash and equivalents has ranged from $769 thousand in 2014 to $334.05 million in 2022, and is currently $16.81 million as of their latest financial filing in 2025.

Over the last 10 years, Claritev's book value per share changed from -1.21 in 2015 to -10.52 in 2025, a change of 767.7%.

Related Companies

Financial statements for NYSE:CTEV last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Claritev (CTEV) Financials

Financials Breakdown Chart

Key Financial Trends

Claritev Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Claritev (CTEV) Financials

Annual Income Statements for Claritev

Quarterly Income Statements for Claritev

Annual Cash Flow Statements for Claritev

Quarterly Cash Flow Statements for Claritev

Annual Balance Sheets for Claritev

Quarterly Balance Sheets for Claritev

Annual Metrics And Ratios for Claritev

Quarterly Metrics And Ratios for Claritev

Financials Breakdown Chart

Key Financial Trends

Claritev Financials - Frequently Asked Questions

When does Claritev's financial year end?

How has Claritev's net income changed over the last 10 years?

How has Claritev's revenue changed over the last 10 years?

How much debt does Claritev have?

How much cash does Claritev have?

How has Claritev's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools